Hyperion Partners’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$17.6K Buy
553
+50
+10% +$1.76K 0.01% 73
2024
Q2
$17.5K Buy
503
+33
+7% +$1.41K 0.01% 71
2024
Q1
$26.9K Hold
470
0.02% 71
2023
Q4
$38.4K Buy
+470
New +$29.3K 0.03% 65

Other funds holding CVM

Hyperion Partners's CVM Position: Q3 2024 in Review

Hyperion Partners increased its CEL-SCI Corp (CVM) stake by 9.9% in Q3 2024, buying an estimated $1.76K and bringing the position to 553 shares worth $17.6K. The position accounts for 0.01% of the portfolio, ranked #73.

Hyperion Partners first reported a position in CVM in Q4 2023 and has held it in 4 quarters since. The position peaked at $38.4K in Q4 2023. 64 funds tracked by Wall St. Rank hold CVM as of Q3 2024.

  • Hyperion Partners held 553 shares of CEL-SCI Corp worth $17.6K as of Q3 2024.
  • Hyperion Partners bought 50 CEL-SCI Corp shares in Q3 2024, an estimated $1.76K.
  • CEL-SCI Corp made up 0.01% of Hyperion Partners's portfolio in Q3 2024, its #73 holding.
  • Hyperion Partners first reported a position in CEL-SCI Corp in Q4 2023 and has held it in 4 quarters since.
  • Hyperion Partners's CEL-SCI Corp position peaked at $38.4K in Q4 2023.
  • 64 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q3 2024.

Based on Hyperion Partners's 13F filing for Q3 2024, filed 9 Oct 2024.